JP2010500535A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500535A5
JP2010500535A5 JP2009523149A JP2009523149A JP2010500535A5 JP 2010500535 A5 JP2010500535 A5 JP 2010500535A5 JP 2009523149 A JP2009523149 A JP 2009523149A JP 2009523149 A JP2009523149 A JP 2009523149A JP 2010500535 A5 JP2010500535 A5 JP 2010500535A5
Authority
JP
Japan
Prior art keywords
renal failure
acute renal
risk
concentration
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009523149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500535A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2007/000366 external-priority patent/WO2008017306A1/en
Publication of JP2010500535A publication Critical patent/JP2010500535A/ja
Publication of JP2010500535A5 publication Critical patent/JP2010500535A5/ja
Pending legal-status Critical Current

Links

JP2009523149A 2006-08-07 2007-08-03 重大な腎損傷を除外するための診断検査 Pending JP2010500535A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83608806P 2006-08-07 2006-08-07
PCT/DK2007/000366 WO2008017306A1 (en) 2006-08-07 2007-08-03 Diagnostic test to exclude significant renal injury

Publications (2)

Publication Number Publication Date
JP2010500535A JP2010500535A (ja) 2010-01-07
JP2010500535A5 true JP2010500535A5 (enExample) 2010-09-02

Family

ID=38645725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523149A Pending JP2010500535A (ja) 2006-08-07 2007-08-03 重大な腎損傷を除外するための診断検査

Country Status (4)

Country Link
US (4) US20100210031A2 (enExample)
EP (2) EP2602624A1 (enExample)
JP (1) JP2010500535A (enExample)
WO (1) WO2008017306A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338096B2 (en) * 2008-04-15 2012-12-25 Rainer Oberbauer Markers of acute kidney failure
US7977110B2 (en) 2008-06-02 2011-07-12 Children's Hospital Medical Center Method for distinguishing between kidney dysfunctions
EP3244213A1 (en) * 2009-02-06 2017-11-15 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2449385A1 (de) * 2009-07-02 2012-05-09 Mosaiques Diagnostics And Therapeutics AG Verfahren und marker zur diagnose eines akuten nierenversagens
CA2780464A1 (en) 2009-10-14 2011-04-21 Rainer Oberbauer Acute kidney injury risk testing
CN102759623A (zh) * 2012-07-06 2012-10-31 南京基蛋生物科技有限公司 一种检测ngal胶体金试纸条及其制备方法
CN104569417B (zh) * 2013-10-12 2016-06-01 广州瑞博奥生物科技有限公司 一种用于早期诊断急性肾损伤的抗体芯片试剂盒

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635091A (en) * 1970-08-31 1972-01-18 Frederick D Linzer Midstream urine specimen and fractional fluid collectors
IT1074038B (it) * 1976-08-05 1985-04-17 Simes Esteri della epinina
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
US4640909A (en) * 1985-05-07 1987-02-03 J. T. Baker Chemical Company Bonded phase of silica and carboalkoxyalkyl silanes for solid phase extraction
US5939272A (en) * 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
JP2912413B2 (ja) * 1990-03-28 1999-06-28 東亜医用電子株式会社 粒度分布作成方法
US5405832A (en) * 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
US5273961A (en) * 1992-09-22 1993-12-28 Genentech, Inc. Method of prophylaxis of acute renal failure
SE9401351D0 (sv) 1994-04-21 1994-04-21 Venge A method for diagnosis
US5552313A (en) * 1994-11-21 1996-09-03 Kansas University DNA encoding mouse phosphotriesterase-related protein
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
US5627034A (en) * 1995-12-05 1997-05-06 Wisconsin Alumni Research Foundation Assay for carcinoma proliferative status by measuring NGAL expression level
JP4602482B2 (ja) * 1996-05-24 2010-12-22 バイオジェン・アイデック・エムエイ・インコーポレイテッド 組織再生のモジュレーター
US6020163A (en) * 1997-08-06 2000-02-01 Zymogenetics, Inc. Lipocalin homolog
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
AUPP784398A0 (en) * 1998-12-21 1999-01-21 Monash University Kidney disease detection and treatment
AU5330200A (en) * 1999-06-18 2001-01-09 Michigan State University Method and apparatus for the detection of volatile products in a sample
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
AU2001293964B2 (en) * 2000-10-03 2007-06-14 Rowett Research Institute Method of assaying pyrrole-containing biological compounds
US7153660B2 (en) * 2000-10-13 2006-12-26 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
FI20010019A7 (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen gastriitin diagnostisoimiseksi
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
EP1322957B1 (en) * 2001-05-04 2009-08-12 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
WO2003029462A1 (en) * 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
US20030119209A1 (en) * 2001-12-21 2003-06-26 Kaylor Rosann Marie Diagnostic methods and devices
US6986995B2 (en) * 2002-02-28 2006-01-17 Prometheus Laboratories, Inc. Methods of diagnosing liver fibrosis
US6847451B2 (en) * 2002-05-01 2005-01-25 Lifescan, Inc. Apparatuses and methods for analyte concentration determination
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US20070275424A1 (en) * 2002-11-22 2007-11-29 Andrew Gewirtz Diagnostic Tests and Methods for Diagnosing Inflammatory Bowel Disease
US7056702B2 (en) * 2002-12-16 2006-06-06 Kimberly Clark Co Detecting lipocalin
DE602004022150D1 (de) † 2003-03-27 2009-09-03 Childrens Hosp Medical Center Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
CA2565701A1 (en) * 2004-05-06 2005-11-17 Jonathan M. Barasch Ngal for reduction and amelioration of ischemic and nephrotoxic injuries
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
CA2511269A1 (en) * 2004-07-07 2006-01-07 F. Hoffmann-La Roche Ag Multimarker panel based on p1gf for diabetes type 1 and 2
US20060105419A1 (en) * 2004-08-16 2006-05-18 Biosite, Inc. Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
DK1831699T3 (da) * 2004-12-20 2010-03-15 Antibodyshop As Bestemmelse af neutrofil gelatine-associeret lipocalin (NGAL) som en diagnostisk markør for nyresygdomme
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US20080090304A1 (en) * 2006-10-13 2008-04-17 Barasch Jonathan Matthew Diagnosis and monitoring of chronic renal disease using ngal
PL2035835T3 (pl) * 2006-05-30 2012-05-31 Antibodyshop As Sposoby szybkiej oceny ciężkości urazu
US20080061149A1 (en) * 2006-09-11 2008-03-13 Colin Tanner Proximity payment card with security interlock
US20090123970A1 (en) * 2007-10-19 2009-05-14 Abbott Laboratories Glycosylated mammalian ngal and use thereof
US20090124022A1 (en) * 2007-10-19 2009-05-14 Abbott Laboratories Antibodies that bind to mammalian ngal and uses thereof
US20090123946A1 (en) * 2007-10-19 2009-05-14 Abbott Laboratories Immunoassays and kits for the detection of ngal

Similar Documents

Publication Publication Date Title
Morgera et al. Intermittent high permeability hemofiltration in septic patients with acute renal failure
Han et al. Urinary biomarkers in the early diagnosis of acute kidney injury
Goknar et al. Determination of early urinary renal injury markers in obese children
JP2010529468A5 (enExample)
KR20110103965A (ko) 급성 신장 손상의 발견 또는 감시 방법, 장치 및 키트
WO2007044994A3 (en) Diagnosis and monitoring of chronic renal disease using ngal
JP2014502347A5 (enExample)
CN102713622B (zh) β淀粉样蛋白的测定方法
Gaikwad et al. Screening for diabetes mellitus using gingival crevicular blood with the help of a self-monitoring device
He et al. Point-of-care COPD diagnostics: Biomarkers, sampling, paper-based analytical devices, and perspectives
JP2014505254A5 (enExample)
RU2008103988A (ru) Способ диагностики рассеяного склероза
Chen et al. Free p-cresol sulfate is associated with survival and function of vascular access in chronic hemodialysis patients
Bevc et al. Simple cystatin C formula compared to serum creatinine-based formulas for estimation of glomerular filtration rate in patients with mildly to moderately impaired kidney function
EP4573371A2 (en) Diagnosis and treatment of acute kidney injury
Bakoush et al. Renal function in proteinuric glomerular diseases correlates to the changes in urine IgM excretion but not to the changes in the degree of albuminuria
Hasan et al. Kidney Injury Molecule-1 (KIM-1), Neutrophil GelatinaseAssociated Lipocalin (NGAL), and CRP: a potential biomarker for early prediction of Acute Kidney Injury (AKI) in pediatric male patients.
JP6693644B2 (ja) 赤血球沈降防止剤
Sonkar et al. A preliminary study on the significant value of beta-2-microglobulin over serum creatinine in renal transplant rejection and renal failure
JP6062439B2 (ja) 早期腎障害の評価マーカーとその測定方法
JACOBSON et al. Renal Size, Glomerular Function and Urinary Excretion of Albumin and β2‐Microglobulin in Patients with Renal Scarring Due to Pyelonephritis
Uğur et al. Effect of a novel extracorporeal cytokine apheresis method on endocan, copeptin and interleukin-6 levels in sepsis: An observational prospective study
Gupta et al. Acute on chronic liver failure: An update
Luoma et al. Saliva and plasma clearance of antipyrine as reflectors of liver function
JP6192177B2 (ja) 炎症性腸疾患のバイオマーカーとしてのｓ１００ａ９の使用